# L_2012341EN.01001301.xml

| 13.12.2012 | EN | Official Journal of the European Union | L 341/13 |
| --- | --- | --- | --- |

13.12.2012

EN

Official Journal of the European Union

L 341/13

---

DECISION OF THE EEA JOINT COMMITTEE

No 162/2012

of 28 September 2012

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Directive 2012/2/EU of 9 February 2012 amending Directive 98/8/EC of the European Parliament and of the Council to include copper (II) oxide, copper (II) hydroxide and basic copper carbonate as active substances in Annex I thereto (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Directive 2012/2/EU of 9 February 2012 amending Directive 98/8/EC of the European Parliament and of the Council to include copper (II) oxide, copper (II) hydroxide and basic copper carbonate as active substances in Annex I thereto (1) is to be incorporated into the EEA Agreement.

| (2) | Commission Directive 2012/3/EU of 9 February 2012 amending Directive 98/8/EC of the European Parliament and of the Council to include bendiocarb as an active substance in Annex I thereto (2) is to be incorporated into the EEA Agreement. |
| --- | --- |

(2)

Commission Directive 2012/3/EU of 9 February 2012 amending Directive 98/8/EC of the European Parliament and of the Council to include bendiocarb as an active substance in Annex I thereto (2) is to be incorporated into the EEA Agreement.

| (3) | Commission Decision 2012/77/EU of 9 February 2012 concerning the non-inclusion of flufenoxuron for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (3) is to be incorporated into the EEA Agreement. |
| --- | --- |

(3)

Commission Decision 2012/77/EU of 9 February 2012 concerning the non-inclusion of flufenoxuron for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (3) is to be incorporated into the EEA Agreement.

| (4) | Commission Decision 2012/78/EU of 9 February 2012 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (4) is to be incorporated into the EEA Agreement. |
| --- | --- |

(4)

Commission Decision 2012/78/EU of 9 February 2012 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (4) is to be incorporated into the EEA Agreement.

| (5) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(5)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

| (1) | the following indents shall be added in point 12n (Directive 98/8/EC of the European Parliament and of the Council):






  ‘— | 32012 L 0002: Commission Directive 2012/2/EU of 9 February 2012 (OJ L 37, 10.2.2012, p. 60), |
| --- | --- | --- |

(1)

the following indents shall be added in point 12n (Directive 98/8/EC of the European Parliament and of the Council):

‘—

32012 L 0002: Commission Directive 2012/2/EU of 9 February 2012 (OJ L 37, 10.2.2012, p. 60),

| — | 32012 L 0003: Commission Directive 2012/3/EU of 9 February 2012 (OJ L 37, 10.2.2012, p. 65).’; |
| --- | --- |

—

32012 L 0003: Commission Directive 2012/3/EU of 9 February 2012 (OJ L 37, 10.2.2012, p. 65).’;

| (2) | the following points shall be inserted after point 12zzf (Commission Regulation (EU) No 440/2010):






  ‘12zzg. | 32012 D 0077: Commission Decision 2012/77/EU of 9 February 2012 concerning the non-inclusion of flufenoxuron for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (OJ L 38, 11.2.2012, p. 47). |
| --- | --- | --- |

(2)

the following points shall be inserted after point 12zzf (Commission Regulation (EU) No 440/2010):

‘12zzg.

| 12zzh. | 32012 D 0078: Commission Decision 2012/78/EU of 9 February 2012 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (OJ L 38, 11.2.2012, p. 48).’. |
| --- | --- |

12zzh.

Article 2

The texts of Directives 2012/2/EU and 2012/3/EU and Decisions 2012/77/EU and 2012/78/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 29 September 2012, provided that all the notifications under Article 103(1) of the EEA Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 28 September 2012.

For the EEA Joint Committee

The President

Atle LEIKVOLL

---

(1)  
  OJ L 37, 10.2.2012, p. 60.

1

(2)  
  OJ L 37, 10.2.2012, p. 65.

2

(3)  
  OJ L 38, 11.2.2012, p. 47.

3

(4)  
  OJ L 38, 11.2.2012, p. 48.

4

(*1)  No constitutional requirements indicated.

*1

---